{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:18:19Z","timestamp":1758845899895,"version":"3.44.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170445"],"award-info":[{"award-number":["82170445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15930-9","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:27:22Z","timestamp":1758806842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of the effects of oxymatrine on myocardial hypertrophy in spontaneously hypertensive rats through transcriptomics and metabolomics"],"prefix":"10.1038","volume":"15","author":[{"given":"Chaohong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"15930_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"15930_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli, F. H., Rimoldi, S. F. & Bangalore, S. The transition from hypertension to heart failure: Contemporary update. JACC Heart Fail. 5, 543\u2013551. https:\/\/doi.org\/10.1016\/j.jchf.2017.04.012 (2017).","journal-title":"JACC Heart Fail."},{"key":"15930_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","volume":"20","author":"J Ritterhoff","year":"2023","unstructured":"Ritterhoff, J. & Tian, R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: New paradigms and challenges. Nat. Rev. Cardiol. 20, 812\u2013829. https:\/\/doi.org\/10.1038\/s41569-023-00887-x (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"15930_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104541","volume":"151","author":"X Lan","year":"2020","unstructured":"Lan, X. et al. Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside. Pharmacol. Res. 151, 104541. https:\/\/doi.org\/10.1016\/j.phrs.2019.104541 (2020).","journal-title":"Pharmacol. Res."},{"key":"15930_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23330","volume":"37","author":"S Seksaria","year":"2023","unstructured":"Seksaria, S. et al. Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involved in diabetes associated cardiomyopathy via SIRT1\/AMPK and TGF-\u03b2 signaling pathway. J. Biochem. Mol. Toxicol. 37, e23330. https:\/\/doi.org\/10.1002\/jbt.23330 (2023).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"15930_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2014.10.001","volume":"745","author":"W Zhang","year":"2014","unstructured":"Zhang, W. et al. Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH\/ADMA metabolism pathway in rats. Eur. J. Pharmacol. 745, 29\u201335. https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.001 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"15930_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.phymed.2012.10.012","volume":"20","author":"XY Huang","year":"2013","unstructured":"Huang, X. Y. & Chen, C. X. Effect of oxymatrine, the active component from Radix Sophorae flavescentis (Kushen), on ventricular remodeling in spontaneously hypertensive rats. Phytomedicine 20, 202\u2013212. https:\/\/doi.org\/10.1016\/j.phymed.2012.10.012 (2013).","journal-title":"Phytomedicine"},{"key":"15930_CR8","doi-asserted-by":"publisher","first-page":"23631","DOI":"10.1074\/jbc.R110.171405","volume":"286","author":"GF Zhang","year":"2011","unstructured":"Zhang, G. F., Sadhukhan, S., Tochtrop, G. P. & Brunengraber, H. Metabolomics, pathway regulation, and pathway discovery. J. Biol. Chem. 286, 23631\u201323635. https:\/\/doi.org\/10.1074\/jbc.R110.171405 (2011).","journal-title":"J. Biol. Chem."},{"key":"15930_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic. Acids. Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic. Acids. Res."},{"key":"15930_CR10","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic. Acids. Res. 44, D457\u2013D462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic. Acids. Res."},{"key":"15930_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.apsb.2017.02.005","volume":"7","author":"X Sang","year":"2017","unstructured":"Sang, X. et al. T cell-associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model. Acta Pharm. Sin. B. 7, 311\u2013318. https:\/\/doi.org\/10.1016\/j.apsb.2017.02.005 (2017).","journal-title":"Acta Pharm. Sin. B."},{"key":"15930_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111000","volume":"124","author":"X Li","year":"2023","unstructured":"Li, X. et al. Oxymatrine inhibits melanoma development by modulating the immune microenvironment and targeting the MYC\/PD-L1 pathway. Int. Immunopharmacol. 124, 111000. https:\/\/doi.org\/10.1016\/j.intimp.2023.111000 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"15930_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circ. Res. 119, 91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577 (2016).","journal-title":"Circ. Res."},{"key":"15930_CR14","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.7150\/thno.74563","volume":"12","author":"P Yue","year":"2022","unstructured":"Yue, P. et al. Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload. Theranostics 12, 7009\u20137031. https:\/\/doi.org\/10.7150\/thno.74563 (2022).","journal-title":"Theranostics"},{"key":"15930_CR15","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.7150\/thno.95908","volume":"14","author":"J Cao","year":"2024","unstructured":"Cao, J. et al. Spatial transcriptomics: A powerful tool in disease understanding and drug discovery. Theranostics 14, 2946\u20132968. https:\/\/doi.org\/10.7150\/thno.95908 (2024).","journal-title":"Theranostics"},{"key":"15930_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.fct.2017.07.031","volume":"109","author":"P Joseph","year":"2017","unstructured":"Joseph, P. Transcriptomics in toxicology. Food Chem. Toxicol. 109, 650\u2013662. https:\/\/doi.org\/10.1016\/j.fct.2017.07.031 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"15930_CR17","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","volume":"139","author":"M Marklund","year":"2019","unstructured":"Marklund, M. et al. Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality. Circulation 139, 2422\u20132436. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038908 (2019).","journal-title":"Circulation"},{"key":"15930_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/hh2101.099268","volume":"89","author":"I Fleming","year":"2001","unstructured":"Fleming, I. Cytochrome p450 and vascular homeostasis. Circ. Res. 89, 753\u2013762. https:\/\/doi.org\/10.1161\/hh2101.099268 (2001).","journal-title":"Circ. Res."},{"key":"15930_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","volume":"179","author":"KL Jamieson","year":"2017","unstructured":"Jamieson, K. L., Endo, T., Darwesh, A. M., Samokhvalov, V. & Seubert, J. M. Cytochrome P450-derived eicosanoids and heart function. Pharmacol. Ther. 179, 47\u201383. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.005 (2017).","journal-title":"Pharmacol. Ther."},{"key":"15930_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ki.1986.204","volume":"30","author":"S Oparil","year":"1986","unstructured":"Oparil, S. The sympathetic nervous system in clinical and experimental hypertension. Kidney Int. 30, 437\u2013452. https:\/\/doi.org\/10.1038\/ki.1986.204 (1986).","journal-title":"Kidney Int."},{"key":"15930_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41392-023-01378-8","volume":"8","author":"S Xie","year":"2023","unstructured":"Xie, S., Xu, S. C., Deng, W. & Tang, Q. Metabolic landscape in cardiac aging: Insights into molecular biology and therapeutic implications. Signal Transduct. Target. Ther. 8, 114. https:\/\/doi.org\/10.1038\/s41392-023-01378-8 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"15930_CR22","doi-asserted-by":"publisher","first-page":"F751","DOI":"10.1152\/ajprenal.00416.2023","volume":"326","author":"MJ Williams","year":"2024","unstructured":"Williams, M. J. et al. In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy. Am. J. Physiol. Renal Physiol. 326, F751\u2013F767. https:\/\/doi.org\/10.1152\/ajprenal.00416.2023 (2024).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"15930_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","volume":"86","author":"B Sarkadi","year":"2006","unstructured":"Sarkadi, B., Homolya, L., Szak\u00e1cs, G. & V\u00e1radi, A. Human multidrug resistance ABCB and ABCG transporters: Participation in a chemoimmunity defense system. Physiol. Rev. 86, 1179\u20131236. https:\/\/doi.org\/10.1152\/physrev.00037.2005 (2006).","journal-title":"Physiol. Rev."},{"key":"15930_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/ATVBAHA.111.240341","volume":"32","author":"Y Higashikuni","year":"2012","unstructured":"Higashikuni, Y. et al. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response. Arterioscler. Thromb. Vasc. Biol. 32, 654\u2013661. https:\/\/doi.org\/10.1161\/ATVBAHA.111.240341 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"15930_CR25","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/biomedicines12081864","volume":"12","author":"CH Huang","year":"2024","unstructured":"Huang, C. H. et al. Sphingolipid metabolism is associated with cardiac dyssynchrony in patients with acute myocardial infarction. Biomedicines 12, 1864. https:\/\/doi.org\/10.3390\/biomedicines12081864 (2024).","journal-title":"Biomedicines"},{"key":"15930_CR26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/01.cir.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber, K. T. & Brilla, C. G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83, 1849\u20131865. https:\/\/doi.org\/10.1161\/01.cir.83.6.1849 (1991).","journal-title":"Circulation"},{"key":"15930_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trsl.2021.08.003","volume":"239","author":"CS Hung","year":"2021","unstructured":"Hung, C. S. et al. Aldosterone suppresses cardiac mitochondria. Transl. Res. 239, 58\u201370. https:\/\/doi.org\/10.1016\/j.trsl.2021.08.003 (2021).","journal-title":"Transl. Res."},{"key":"15930_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1097\/HJH.0b013e328326cb04","volume":"27","author":"T Ohtani","year":"2009","unstructured":"Ohtani, T. et al. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure. J. Hypertens. 27, 1074\u20131083. https:\/\/doi.org\/10.1097\/HJH.0b013e328326cb04 (2009).","journal-title":"J. Hypertens."},{"key":"15930_CR29","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1161\/HYPERTENSIONAHA.122.20809","volume":"80","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Indoleamine 2,3-dioxygenase 1 deletion-mediated kynurenine insufficiency inhibits pathological cardiac hypertrophy. Hypertension 80, 2099\u20132111. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.20809 (2022).","journal-title":"Hypertension"},{"key":"15930_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2265.1993.tb01782.x","volume":"39","author":"HA Spoudeas","year":"1993","unstructured":"Spoudeas, H. A., Slater, J. D., Rumsby, G., Honour, J. W. & Brook, C. G. Deoxycorticosterone, 11 beta-hydroxylase and the adrenal cortex. Clin. Endocrinol. 39, 245\u2013251. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb01782.x (1993).","journal-title":"Clin. Endocrinol."},{"key":"15930_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12906-016-1231-9","volume":"16","author":"L Fu","year":"2016","unstructured":"Fu, L. et al. Oxymatrine inhibits aldosterone-induced rat cardiac fibroblast proliferation and differentiation by attenuating Smad-2, -3, and -4 expression: An in vitro study. BMC Complement. Altern. Med. 16, 241. https:\/\/doi.org\/10.1186\/s12906-016-1231-9 (2016).","journal-title":"BMC Complement. Altern. Med."},{"key":"15930_CR32","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.12659\/MSM.915542","volume":"25","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Inhibitory effects of oxymatrine on transdifferentiation of neonatal rat cardiac fibroblasts to myofibroblasts induced by aldosterone via Keap1\/Nrf2 signaling pathways in vitro. Med. Sci. Monit. 25, 5375\u20135388. https:\/\/doi.org\/10.12659\/MSM.915542 (2019).","journal-title":"Med. Sci. Monit."},{"key":"15930_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088856","volume":"9","author":"TT Xiao","year":"2014","unstructured":"Xiao, T. T., Wang, Y. Y., Zhang, Y., Bai, C. H. & Shen, X. C. Similar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signaling. PLoS ONE 9, 88856. https:\/\/doi.org\/10.1371\/journal.pone.0088856 (2014).","journal-title":"PLoS ONE"},{"key":"15930_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/s1734-1140(11)70613-2","volume":"63","author":"MP Baldo","year":"2011","unstructured":"Baldo, M. P. et al. Long-term use of low-dose spironolactone in spontaneously hypertensive rats: effects on left ventricular hypertrophy and stiffness. Pharmacol. Rep. 63, 975\u2013982. https:\/\/doi.org\/10.1016\/s1734-1140(11)70613-2 (2011).","journal-title":"Pharmacol. Rep."},{"key":"15930_CR35","doi-asserted-by":"publisher","first-page":"4680732","DOI":"10.1155\/2017\/4680732","volume":"2017","author":"WA Garc\u00eda-Su\u00e1stegui","year":"2017","unstructured":"Garc\u00eda-Su\u00e1stegui, W. A. et al. The role of CYP2E1 in the drug metabolism or bioactivation in the brain. Oxid. Med. Cell. Longev. 2017, 4680732. https:\/\/doi.org\/10.1155\/2017\/4680732 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"15930_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-94-007-5881-0_7","volume":"67","author":"MR Lakshman","year":"2013","unstructured":"Lakshman, M. R. et al. CYP2E1, oxidative stress, post-translational modifications and lipid metabolism. Subcell. Biochem. 67, 199\u2013233. https:\/\/doi.org\/10.1007\/978-94-007-5881-0_7 (2013).","journal-title":"Subcell. Biochem."},{"key":"15930_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.18388\/abp.2020_6517","volume":"70","author":"O Maksymchuk","year":"2023","unstructured":"Maksymchuk, O., Shysh, A. & Kotliarova, A. Quercetin inhibits the expression of MYC and CYP2E1 and reduces oxidative stress in the myocardium of spontaneously hypertensive rats. Acta Biochim. Pol. 70, 199\u2013204. https:\/\/doi.org\/10.18388\/abp.2020_6517 (2023).","journal-title":"Acta Biochim. Pol."},{"key":"15930_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22970","volume":"9","author":"S Zhou","year":"2023","unstructured":"Zhou, S. et al. Parishin treatment alleviates cardiac aging in naturally aged mice. Heliyon 9, 22970. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22970 (2023).","journal-title":"Heliyon"},{"key":"15930_CR39","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/j.1742-4658.2011.08063.x","volume":"278","author":"W Zhang","year":"2011","unstructured":"Zhang, W. et al. Expression of CYP2E1 increases oxidative stress and induces apoptosis of cardiomyocytes in transgenic mice. FEBS J. 278, 1484\u20131492. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08063.x (2011).","journal-title":"FEBS J."},{"key":"15930_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1161\/HYPERTENSIONAHA.112.191478","volume":"60","author":"D Lu","year":"2012","unstructured":"Lu, D. et al. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension 60, 81\u201389. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.191478 (2012).","journal-title":"Hypertension"},{"key":"15930_CR41","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1124\/dmd.108.023077","volume":"36","author":"BN Zordoky","year":"2008","unstructured":"Zordoky, B. N., Aboutabl, M. E. & El-Kadi, A. O. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metab. Dispos. 36, 2277\u20132286. https:\/\/doi.org\/10.1124\/dmd.108.023077 (2008).","journal-title":"Drug Metab. Dispos."},{"key":"15930_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0026-895X(24)13076-3","volume":"54","author":"HM Peng","year":"1998","unstructured":"Peng, H. M. & Coon, M. J. Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Mol. Pharmacol. 54, 740\u2013747 (1998).","journal-title":"Mol. Pharmacol."},{"key":"15930_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/004982599238461","volume":"29","author":"GF Chen","year":"1999","unstructured":"Chen, G. F., Ronis, M. J., Ingelman-Sundberg, M. & Badger, T. M. Hormonal regulation of microsomal cytochrome P4502E1 and P450 reductase in rat liver and kidney. Xenobiotica 29, 437\u2013451. https:\/\/doi.org\/10.1080\/004982599238461 (1999).","journal-title":"Xenobiotica"},{"key":"15930_CR44","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3892\/etm.2021.9988","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Oxymatrine pretreatment protects H9c2 cardiomyocytes from hypoxia\/reoxygenation injury by modulating the PI3K\/Akt pathway. Exp. Ther. Med. 21, 556. https:\/\/doi.org\/10.3892\/etm.2021.9988 (2021).","journal-title":"Exp. Ther. Med."},{"key":"15930_CR45","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1210\/endo-108-4-1216","volume":"108","author":"J Sowers","year":"1981","unstructured":"Sowers, J., Tuck, M., Asp, N. D. & Sollars, E. Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats. Endocrinology 108, 1216\u20131221. https:\/\/doi.org\/10.1210\/endo-108-4-1216 (1981).","journal-title":"Endocrinology"},{"key":"15930_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cardiores.2006.02.010","volume":"70","author":"K Lister","year":"2006","unstructured":"Lister, K., Autelitano, D. J., Jenkins, A., Hannan, R. D. & Sheppard, K. E. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1. Cardiovasc. Res. 70, 555\u2013565. https:\/\/doi.org\/10.1016\/j.cardiores.2006.02.010 (2006).","journal-title":"Cardiovasc. Res."},{"key":"15930_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13318-024-00923-2","volume":"50","author":"Y Pan","year":"2025","unstructured":"Pan, Y. et al. Hypertensive nephropathy changes the expression of drug-metabolizing enzymes and transporters in spontaneously hypertensive rat liver and kidney. Eur. J. Drug Metab. Pharmacokinet. 50, 39\u201351. https:\/\/doi.org\/10.1007\/s13318-024-00923-2 (2025).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15930-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15930-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15930-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:27:23Z","timestamp":1758806843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15930-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15930"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15930-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in this study were in accordance with national animal research regulations, and all animal experimental protocols complied with the ARRIVE guidelines and were approved by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University (No: 2021347).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"32810"}}